Skip to main content
Dot gov

Official websites use the Texas HHS logo.
The Texas HHS logo means this is an official website of Texas Health and Human Services.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Hepatitis C Direct-Acting Antivirals - Index

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Vendor Drug Program formulary coverage.  

Note: This retrospective drug use criteria set provides information from each respective therapies FDA approved package insert. Further guidance for patient specific treatments can be found within the continuously updated American Association for the Study of Liver Disease (AASLD) and the Infectious Diseases Society of America (IDSA) “HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C” guidelines at hcvguidelines.org. It is recommended to consult these guidelines prior to initiating therapy to treat hepatitis C infection.1 

  • Revision history
    • July 24, 2024
    • July 22, 2022
    • March 2018 (Initially developed)